Your browser doesn't support javascript.
loading
The effectiveness of radiofrequency ablation for patients with BCLC B1 stage hepatocellular carcinoma downgraded by transarterial chemoembolization.
Li, Lu; Xin, Yujing; Zhang, Xinyuan; Chen, Yi; Yang, Yi; Zhou, Xiang; Ye, Feng.
Affiliation
  • Li L; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, 100021, China.
  • Xin Y; Department of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Zhang X; Department of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Chen Y; Department of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Yang Y; Department of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Zhou X; Department of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. Electronic address: zhou.xiang@yeah.net.
  • Ye F; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, 100021, China. Electronic address: dr_fengye_ncc@163.com.
Clin Res Hepatol Gastroenterol ; 46(4): 101878, 2022 04.
Article de En | MEDLINE | ID: mdl-35151909

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Chimioembolisation thérapeutique / Ablation par cathéter / Carcinome hépatocellulaire / Ablation par radiofréquence / Tumeurs du foie Type d'étude: Observational_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Clin Res Hepatol Gastroenterol Année: 2022 Type de document: Article Pays d'affiliation: Chine Pays de publication: France

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Chimioembolisation thérapeutique / Ablation par cathéter / Carcinome hépatocellulaire / Ablation par radiofréquence / Tumeurs du foie Type d'étude: Observational_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Clin Res Hepatol Gastroenterol Année: 2022 Type de document: Article Pays d'affiliation: Chine Pays de publication: France